Aspirin Found to Reduce Melanoma Risk

A study sponsored by the National Institutes of Health has revealed that postmenopausal women who used aspirin regularly had a reduced risk of developing melanoma. Those who had been taking aspirin for less than a year had about an 11 percent reduction, those who had been taking aspirin regularly for one to four years had a 20 percent reduction, and those taking it for five years or longer were 30 percent less likely to develop melanoma than non-users. However, it is important to note that regular users of acetaminophen had the same melanoma incidence as non-users, and three-quarters of aspirin users were on regular or extra-strength doses. No conclusions could be drawn as to whether low-dose aspirin has the same chemopreventive effects. It looks as though an aspirin a day may help keep skin cancer away.

Suggested Articles

Alma Hybrid helps with skin rejuvenation and scar revision.

Carniol is the founder of Carniol Plastic Surgery and has been an active member of the academy for nearly 30 years.

The esthetics company has also acquired Luminera’s R&D pipeline.